News
Hyperfine
HYPR · NASDAQ
$0.774−$0.0032 (−0.41%)TodayMarket closed ·
Prev close $0.7772
Latest news
- Press releaseBusiness Wire
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million
- Press releaseBusiness Wire
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
- Press releaseBusiness Wire
Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets
- Press releaseBusiness Wire
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
- Press releaseBusiness Wire
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
- Press releaseBusiness Wire
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
- Press releaseBusiness Wire
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
- Press releaseBusiness Wire
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
- Press releaseBusiness Wire
Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care
- Press releaseBusiness Wire
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026
- Press releaseBusiness Wire
Hyperfine Announces European Launch of Next-Generation Swoop® System
- Press releaseBusiness Wire
Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care
- Press releaseBusiness Wire
Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
- Press releaseBusiness Wire
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
- Press releaseBusiness Wire
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
- News
Hyperfine Q1 2026 Earnings Call Transcript
- Press releaseBusiness Wire
Hyperfine, Inc. Reports First Quarter 2026 Financial Results
- News
Earnings Scheduled For May 12, 2026
- Press releaseBusiness Wire
Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference
- Press releaseBusiness Wire
Hyperfine Swoop® System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical Institution
- Press releaseBusiness Wire
Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026
- Press releaseBusiness Wire
Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software
- Press releasePRNewswire
How Decentralized AI is Unlocking Value in Cardiac Diagnostics
- Press releaseBusiness Wire
Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine
- Press releaseBusiness Wire
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
- News
Earnings Scheduled For March 18, 2026
- Press releaseBusiness Wire
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
- Press releaseBusiness Wire
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System's Enhanced Stroke Detection Capabilities
- Press releaseBusiness Wire
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
- News
Earnings Scheduled For November 13, 2025
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Dow Dips Over 100 Points; US Crude Oil Inventories Surge
- NewsAvi Kapoor
Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings
- News
Hyperfine Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.